Background

Jennifer Giandhari joined our group studies as a postdoctoral researcher under the supervision of Prof. Tulio de Oliveira. Her postdoctoral research focuses on identifying new drug resistance mutations to protease inhibitors outside of the protease gene by using a genomics and bioinformatics approach. This will assist in the management of patients failing second-line therapy and help guide effective third line options. The project forms part of the Southern African Treatment Resistance Network (SATuRN) and will provide the largest sample dataset of patients failing protease inhibitors in South Africa.

Current Affiliations:

NGS Platform Manager: KRISP - KwaZulu-Natal Research and Innovation Sequencing Platform, UKZN, Durban, South Africa.

Post-Doctoral fellow: College of Health Sciences, University of KwaZulu-Natal (UKZN), Durban, South Africa.

DST-NRF PDP felllow, Centre for the Aids Programme of Research in South Africa (CAPRISA), Durban, South Africa.

Education:

PhD in Virology from the University of Witwatersrand in 2015.

MSc in Virology from the Nelson R Mandela School of Medicine, UKZN, in 2012.